Vir and GlaxoSmithKline begin pivotal study of Covid-19 antibody drug
MATT WINKELMEYER/GETTY IMAGES
The companies lag other drug makers developing antibody treatments but they expect their treatment could have certain advantages.
SE ORDENA RETROTRAER LOS PRECIOS DE LA MEDICINA PREPAGA
Hace 12 horas
.png)
No hay comentarios:
Publicar un comentario